Researchers looked at whether combining blood tests for tumor markers with detailed CT scans could help doctors better determine if a solitary lung nodule is cancerous or benign. They studied 110 patients who already had lung nodules, comparing 45 with benign nodules to 65 with malignant ones. The study found that patients with cancerous nodules tended to have higher levels of certain tumor markers in their blood and showed different features on their CT scans than those with benign nodules.
When doctors used both the blood tests and CT scans together, they were able to correctly identify 96.9% of the cancerous nodules with 87.3% overall accuracy. This combined approach performed better than using either blood tests or imaging alone. The study did not report any safety concerns related to these diagnostic methods, which are already commonly used in medicine.
It's important to understand this was a retrospective study, meaning researchers looked back at existing patient data rather than following patients forward in time. This design has limitations and cannot prove that the combined approach causes better outcomes. The study was also relatively small with only 110 patients.
Readers should know this research suggests a promising direction for assessing lung nodules, but more studies are needed before this combined approach becomes standard practice. If you have a lung nodule, your doctor will consider many factors when determining the best approach for your individual situation.
